SHPH Stock Analysis: Buy, Sell, or Hold?
SHPH - Shuttle Pharmaceuticals Holdings, Inc. Common Stock
$3.76
0.05 (1.35%)
â˛
5d:
-7.62%
30d:
+25.75%
90d:
+513.88%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 25, 2026
TODAY
Get Alerted When SHPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SHPH is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SHPH is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SHPH is currently trading at $3.76, which is considered fair relative to its 30-day fair value range of $3.07 to $4.21.
Technical Outlook: Technically, SHPH is in a strong uptrend. Immediate support is located at $3.53, while resistance sits at $4.80.
Market Sentiment: SHPH scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SHPH is in a strong uptrend. Immediate support is located at $3.53, while resistance sits at $4.80.
Market Sentiment: SHPH scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.07 -
$4.21
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.1%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.07 -
$4.21
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.53
Resistance Level
$4.80
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Share & Embed Analysis
Last updated: August 24, 2026 7:42 AM ET
Data refreshes hourly during market hours. Next update: 8:42 AM
Data refreshes hourly during market hours. Next update: 8:42 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SHPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences IâĻ |
STRONG BUY
25 analysts |
$212 | 67 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 56 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$101 | 43 HOLD |
|
UTHR
United Therapeutics CorpâĻ |
STRONG BUY
15 analysts |
$664 | 48 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 55 HOLD |
